{"id":256780,"title":"Consultation of Draft Guidance Documents: Identifying and Labelling Medicinal Ingredients, Generic Drug Equivalence: Medicinal Ingredients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T15:47:01.170000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence.html?wbdisable=true","snippet":"Consultation of Draft Guidance Documents: Identifying and Labelling Medicinal Ingredients, Generic Drug Equivalence: Medicinal Ingredients - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca…","rawSnapshotUrl":"/api/snapshots/raw/256780","browseUrl":"https://replay.healtharchive.ca/job-1/20250418154701/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence.html?wbdisable=true#ha_snapshot=256780","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}